Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 13 04:00PM ET
27.65
Dollar change
-0.01
Percentage change
-0.04
%
IndexS&P 500 P/E- EPS (ttm)-0.06 Insider Own0.04% Shs Outstand5.67B Perf Week-3.99%
Market Cap156.68B Forward P/E10.13 EPS next Y2.73 Insider Trans0.13% Shs Float5.66B Perf Month-2.57%
Income-288.00M PEG- EPS next Q0.45 Inst Own68.66% Short Float1.34% Perf Quarter-1.71%
Sales55.09B P/S2.84 EPS this Y27.63% Inst Trans0.52% Short Ratio1.95 Perf Half Y-3.25%
Book/sh16.28 P/B1.70 EPS next Y16.24% ROA-0.14% Short Interest75.97M Perf Year-31.36%
Cash/sh2.10 P/C13.14 EPS next 5Y-0.53% ROE-0.30% 52W Range25.20 - 40.37 Perf YTD-3.96%
Dividend Est.1.69 (6.11%) P/FCF30.69 EPS past 5Y-27.43% ROI-0.19% 52W High-31.50% Beta0.67
Dividend TTM1.66 (6.00%) Quick Ratio0.78 Sales past 5Y10.96% Gross Margin48.87% 52W Low9.72% ATR (14)0.61
Dividend Ex-DateMay 09, 2024 Current Ratio1.05 EPS Y/Y TTM-101.00% Oper. Margin3.23% RSI (14)43.45 Volatility2.06% 2.01%
Employees88000 Debt/Eq0.75 Sales Y/Y TTM-40.73% Profit Margin-0.52% Recom2.31 Target Price32.57
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q-43.40% Payout439.41% Rel Volume0.87 Prev Close27.66
Sales Surprise7.25% EPS Surprise58.98% Sales Q/Q-18.61% EarningsMay 01 BMO Avg Volume38.91M Price27.65
SMA20-3.51% SMA500.57% SMA200-5.38% Trades Volume33,806,883 Change-0.04%
Date Action Analyst Rating Change Price Target Change
Mar-22-24Downgrade Argus Buy → Hold
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Oct-16-23Upgrade Jefferies Hold → Buy $38 → $39
Jul-17-23Reiterated JP Morgan Neutral $45 → $41
Jul-14-23Initiated HSBC Securities Buy $50
Jun-29-23Downgrade Credit Suisse Outperform → Neutral $47 → $40
May-11-23Downgrade Daiwa Securities Outperform → Neutral $38
Mar-06-23Initiated Jefferies Hold $43
Jun-13-24 04:04PM
01:07PM
01:03PM
11:50AM
08:40AM
07:00AM Loading…
07:00AM
06:33AM
05:21AM
04:12AM
Jun-12-24 05:45PM
05:02PM
04:30PM
01:46PM
12:57PM
10:00AM
08:35AM Loading…
08:35AM
08:28AM
Jun-11-24 02:49PM
12:58PM
10:00AM
08:37AM
08:20AM
08:02AM
06:00AM
05:21AM
05:10AM
Jun-10-24 09:00AM
Jun-08-24 06:50AM
Jun-07-24 03:02PM
10:19AM
09:30AM Loading…
09:30AM
08:03AM
Jun-06-24 04:37PM
09:28AM
Jun-05-24 06:21PM
04:05PM
09:49AM
09:30AM
07:45AM
06:40AM
Jun-04-24 01:59PM
01:45PM
10:43AM
07:23AM
07:15AM
06:37AM
06:00AM
05:29AM
Jun-03-24 04:20PM
04:17PM
03:41PM
12:54PM
10:00AM
06:46AM
06:46AM
06:00AM
Jun-02-24 08:00AM
07:22AM
06:30AM
Jun-01-24 08:54AM
08:00AM
08:00AM
03:00AM
May-31-24 05:01PM
12:20PM
12:18PM
12:07PM
11:53AM
11:31AM
10:56AM
10:23AM
08:04AM
08:00AM
07:07AM
05:47AM
03:30AM
May-30-24 04:03PM
11:44AM
09:22AM
06:40AM
05:45AM
04:45AM
May-29-24 04:23PM
10:07AM
09:31AM
06:30AM
06:00AM
May-28-24 10:11AM
09:00AM
06:22AM
May-27-24 06:58PM
06:55PM
06:47PM
06:43PM
06:34PM
06:28PM
06:28PM
06:13PM
12:59PM
May-26-24 05:39AM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEOFeb 23 '24Option Exercise27.34127,6743,490,607439,748Feb 27 01:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23 '24Option Exercise27.3495,7552,617,942230,920Feb 27 01:46 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23 '24Option Exercise27.3463,8371,745,304218,148Feb 27 01:46 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23 '24Option Exercise27.3429,436804,780123,073Feb 27 01:46 PM
McDermott MichaelExecutive Vice PresidentFeb 23 '24Option Exercise27.3412,412339,34495,408Feb 27 01:47 PM
SAHNI PAYALExecutive Vice PresidentFeb 23 '24Option Exercise27.3411,527315,14834,604Feb 27 01:46 PM
BOSHOFF CHRISTOFFELExecutive Vice PresidentFeb 23 '24Option Exercise27.349,752266,620148,703Feb 27 01:44 PM
DAMICO JENNIFER B.SVP & ControllerFeb 23 '24Option Exercise27.349,752266,62019,228Feb 27 01:46 PM
Gottlieb ScottDirectorDec 15 '23Buy26.473,00079,4019,000Dec 19 09:31 AM